Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Intendis GmbH |
---|---|
Information provided by: | Intendis GmbH |
ClinicalTrials.gov Identifier: | NCT00617903 |
This exploratory study is being performed to determine whether a new form formulation of azelaic acid 15% is effective in the treatment of papulopustular rosecea.
Condition | Intervention | Phase |
---|---|---|
Papulopustular Rosacea |
Drug: Azelaic acid Drug: Vehicle |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | A 12-week Exploratory, Multicenter, Double-blind, Vehicle-controlled Study to Investigate the Efficacy and Safety of Topical Azelaic Acid 15% Foam Twice Daily in Patients With Papulopustular Rosacea |
Estimated Enrollment: | 84 |
Study Start Date: | January 2008 |
Study Completion Date: | June 2008 |
Primary Completion Date: | May 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Experimental
Azelaic acid 15% foam
|
Drug: Azelaic acid
15% foam to be applied topically twice daily
|
2: Placebo Comparator
Vehicle
|
Drug: Vehicle
Active-ingredient free vehicle to be applied topically twice daily
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Responsible Party: | Intendis GmbH ( Dr Klaus Graupe ) |
Study ID Numbers: | 1402140, IND 77,516 |
Study First Received: | January 22, 2008 |
Last Updated: | July 22, 2009 |
ClinicalTrials.gov Identifier: | NCT00617903 History of Changes |
Health Authority: | United States: Food and Drug Administration |
rosacea papulopustular azelaic acid foam |
Rosacea Azelaic acid Skin Diseases |
Rosacea Azelaic acid Skin Diseases Antineoplastic Agents |
Therapeutic Uses Dermatologic Agents Pharmacologic Actions |